Instil Bio, Inc. (TIL) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.34M | -7.08M | -10.56M | -14.79M | -4.2M | -10.56M | -20.13M | -10.61M | -14.39M | -13.38M | -14.43M | -19.56M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 68.13% | 32.99% | 47.56% | -39.38% | 70.85% | 21.09% | -39.56% | 45.75% | 58.48% | 63.81% | 64.71% | 58.61% |
| Net Income | -4.2M | -8.19M | -13.59M | -21.39M | -28.2M | -11.89M | -23.02M | -14.92M | -24.3M | -12.93M | -67.43M | -18.66M |
| Depreciation & Amortization | 12K | 12K | 12K | 12K | 498K | 741K | 901K | 975K | 993K | 1.04M | 953K | 991K |
| Stock-Based Compensation | 985K | 0 | 1.77M | 1.82M | 3.5M | 4.5M | 4.07M | 4.17M | 4.51M | 4.55M | 4.67M | 4.41M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.1M | 0 | -2.25M |
| Other Non-Cash Items | 573K | 975K | 509K | 9.81M | 16.39M | 168K | 7.25M | 180K | 2.58M | 2.11M | 46.15M | 1.32M |
| Working Capital Changes | 1.3M | 128K | 741K | -5.05M | 3.62M | -4.07M | -9.33M | -1.02M | 1.82M | -1.05M | 1.23M | -5.38M |
| Change in Receivables | -304K | -304K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 17K | -148K | 403K | 237K | -376K | -522K | -45K | -9K | 20K | -477K | -425K | 753K |
| Cash from Investing | -317K | 7.82M | 8.45M | -400K | 9.61M | 13M | 19.81M | 11.92M | 9.24M | 13.95M | 2.32M | 10.33M |
| Capital Expenditures | 0 | -10M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -58K | -5.16M | -6.98M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 9K | 5K | 0 | 405K | 0 | -541K | 541K | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 10M | -10M | 13K | 0 | 320K | -11.04M | 0 | 0 | 1.56M | 0 | 0 |
| Cash from Financing | 0 | 0 | 378K | 6.68M | 232K | 1.6M | 159K | 0 | 0 | 1.01M | -587K | 4.2M |
| Debt Issued (Net) | 0 | 6.61M | 0 | 0 | 0 | 2.76M | 0 | 0 | 0 | -587K | 0 | 4.2M |
| Equity Issued (Net) | 0 | -6.61M | 378K | 0 | 404K | 206K | 159K | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 6.68M | -172K | -1.37M | 0 | 0 | 0 | 1.6M | -587K | 0 |
| Net Change in Cash | -1.66M | 723K | -1.76M | -8.49M | 5.69M | 3.97M | -118K | 1.3M | -5.21M | 1.56M | -12.63M | -5.1M |
| Free Cash Flow | -1.34M | -7.08M | -10.56M | -14.79M | -4.2M | -10.56M | -20.13M | -10.61M | -14.39M | -13.44M | -19.58M | -26.54M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 68.13% | 32.99% | 47.56% | -39.38% | 70.85% | 21.43% | -2.8% | 60.02% | 66.63% | 73.12% | 70.36% | 63.84% |
| FCF per Share | -0.20 | -1.04 | -1.56 | -2.24 | -0.64 | -1.62 | -3.09 | -1.63 | -2.21 | -2.07 | -3.01 | -4.08 |
| FCF Conversion (FCF/Net Income) | 0.32x | 0.86x | 0.78x | 0.69x | 0.15x | 0.89x | 0.87x | 0.71x | 0.59x | 1.04x | 0.21x | 1.05x |
| Interest Paid | 0 | 0 | 0 | 1.39M | 886K | 2.76M | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |